Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Government Medical College, Patiala
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients above the age of 18 years 2) Patients diagnosed with HIV 3) PLHIV registered at ART Centre in Government Medical College and Rajindra Hospital, Patiala 4) Treatment naïve PLHIV initiated on Tenofovir 300 mg, Lamivudine 300 mg, Dolutegravir 50 mg, fixed-dose combination regimen 5) PLHIV on TLD with a minimum of 2 drug refills irrespective of follow-up period
Exclusion criteria
Exclusion criteria: 1) Records with incomplete data on ART adherence 2) PLHIV not on Tenofovir 300 mg, Lamivudine 300 mg, Dolutegravir 50 mg, fixed-dose combination regimen 3) PLHIV whose ART regimen was switched during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Adherence rate in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen. 2) Factors associated with adherence in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen. Timepoint: Medical records for all patients put on anti-retroviral therapy fulfilling the inclusion and exclusion criteria will be reviewed on a retrospective basis for a duration of three consecutive months. All visits that the patient has completed within a period of one year from date of initiation of ART will be considered. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Adherence between different age groups in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen. 2) Adherence between gender in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen. 3) Adherence between socio-economic classes in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen. 4) Adherence between WHO Clinical Stages in people living with HIV on Tenofovir, Lamivudine, and Dolutegravir regimen.Timepoint: Medical records for all patients put on anti-retroviral therapy fulfilling the inclusion and exclusion criteria will be reviewed on a retrospective basis for a duration of three consecutive months. All visits that the patient has completed within a period of one year from date of initiation of ART will be considered. | — |
Countries
India
Contacts
Public ContactDr Anjleen Kaur
Government Medical College, Patiala
Outcome results
None listed